Developmental Research Program

发展研究计划

• 批准号: 10709235
• 负责人: ROBERT C BAST
• 金额: $ 8.52万
• 依托单位: UNIVERSITY OF TX MD ANDERSON CAN CTR
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-19 至 2028-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10709235
• 关键词: Address; Ally; Area; Award; Basic Science; Budgets; Cancer Center; Clinical; Clinical Investigator; Clinical Research; Collaborations; Data; Dedications; Department of Defense; Development; Discipline; Disease; Early Diagnosis; Early treatment; Financial Support; Foundations; Funding; Funding Mechanisms; Future; Goals; Human; Incidence; Institution; Malignant Neoplasms; Malignant neoplasm of ovary; Manuscripts; Medical center; Ovarian; Peer Review; Population Research; Prevention; Productivity; Program Research Project Grants; Publishing; Quality of life; Research; Research Personnel; Research Project Grants; Resources; Rest; Scientist; Specimen; Texas; Translational Research; University of Texas M D Anderson Cancer Center; Woman; Work; anticancer research; candidate identification; design; improved; innovation; mortality; novel; ovarian cancer prevention; patient population; peer; programs; supportive environment; translational potential; translational study

Developmental Research Program SUMMARY/ABSTRACT The purpose of the Developmental Research Program (DRP) is to fund promising projects by investigators whose current work may not focus exclusively on ovarian cancer, but who propose highly innovative translational studies of ovarian cancer that could become full SPORE projects or compete successfully for funding outside of the SPORE. The DRP provides a unique opportunity for making available significant financial support, and for demonstrating active institutional support, through a program that is rapidly responsiveto new ideas or initiatives. Moreover, this program is rooted in a spirit of collaboration promoted by the SPORE investigators who have an extensive track record of bringing investigators from other disciplines into ovarian cancer research. The strength of the DRP rests in its ability to make available financial support needed to access all the critical expertise and resources within the entire SPORE. This will allow us to develop collaborative, multi-investigator, multi-institutional research projects with the support of innovative, investigator- initiated projects that have the potential to flourish into reliable and productive translational research projects that make a path from basic and/or population research projects into research focused on human clinical specimens/patient populations. Over the course of the past decade, the MD Anderson OvarianSPORE has supported DRP projects from 22 investigators. Collectively, these investigators have published 470 peer- reviewed manuscripts related to ovarian cancer. Thirteen of the recipients have received peer-reviewedfunding in ovarian cancer as either PI, Co-PI or Co-Investigator. The investigators have received funding from three R01s, three R21s, three CPRIT awards, two Department of Defense Awards and four OCRA awards. One awardee in the most recently funded cycle just received support from both the Ovarian Cancer Research Alliance and Foundation for Women’s Cancer. Additionally, three former awardees have participated in full SPORE projects after completing a DRP project.

发展研究计划摘要/摘要 发展研究计划 (DRP) 的目的是资助研究人员有前途的项目 他们目前的工作可能不仅仅专注于卵巢癌，但提出了高度创新的建议 卵巢癌的转化研究可能成为完整的 SPORE 项目或成功竞争 SPORE 之外的资金为提供大量资金提供了独特的机会。 通过快速响应新的计划来提供支持，并展示积极的机构支持 此外，该计划植根于 SPORE 所倡导的合作精神。 拥有将其他学科的研究人员带入卵巢的广泛记录的研究人员 DRP 的优势在于其提供癌症研究所需的财政支持的能力。 获得整个 SPORE 内的所有关键专业知识和资源，这将使我们能够发展。 在创新、研究者的支持下开展协作、多研究者、多机构研究项目 发起的项目有可能发展成为可靠且富有成效的转化研究项目 开辟从基础和/或人群研究项目到关注人类临床研究的道路 在过去的十年中，MD 安德森 OvarianSPORE 已经 22 位研究人员支持了 DRP 项目，这些研究人员总共发表了 470 篇同行论文。 审阅了与卵巢癌相关的手稿，其中 13 名获奖者已获得同行评审的资助。 作为 PI、Co-PI 或 Co-Investigator 进行卵巢癌研究的研究人员已收到来自三位的资助。 R01、三架 R21、三项 CPRIT 奖项、两项国防部奖项和四项 OCRA 奖项。 最近资助周期的获奖者刚刚获得了卵巢癌研究联盟和 此外，三名前获奖者还参与了完整的 SPORE 项目。 完成 DRP 项目后。